Polyunsaturated fatty acids drive neutrophil extracellular trap formation in nonalcoholic steatohepatitis.

[1]  Shuofei Yang,et al.  Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications , 2022, Nature Communications.

[2]  Xia Li,et al.  HMGB1-Mediated Neutrophil Extracellular Trap Formation Exacerbates Intestinal Ischemia/Reperfusion-Induced Acute Lung Injury , 2022, The Journal of Immunology.

[3]  H. Tilg,et al.  Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity , 2021, Nature Metabolism.

[4]  E. Gautier,et al.  Immune cell-mediated features of non-alcoholic steatohepatitis , 2021, Nature Reviews Immunology.

[5]  Sanni Kumar,et al.  Neutrophil extracellular traps and organ dysfunction in sepsis. , 2021, Clinica chimica acta; international journal of clinical chemistry.

[6]  Guangji Wang,et al.  Silybin Restored CYP3A Expression through the Sirtuin 2/Nuclear Factor κ-B Pathway in Mouse Nonalcoholic Fatty Liver Disease , 2021, Drug Metabolism and Disposition.

[7]  R. Rodrigues,et al.  Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223-enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis. , 2020, The Journal of clinical investigation.

[8]  Joon Seo Lim,et al.  Sphingomyelin synthase 1 mediates hepatocyte pyroptosis to trigger non-alcoholic steatohepatitis , 2020, Gut.

[9]  L. Gershwin,et al.  A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics , 2020, Clinical Reviews in Allergy & Immunology.

[10]  D. Wagner,et al.  Cellular Mechanisms of NETosis. , 2020, Annual review of cell and developmental biology.

[11]  Jing Xie,et al.  Kaempferol blocks neutrophil extracellular traps formation and reduces tumour metastasis by inhibiting ROS‐PAD4 pathway , 2020, Journal of cellular and molecular medicine.

[12]  Liying Li,et al.  Neutrophils undergo switch of apoptosis to NETosis during murine fatty liver injury via S1P receptor 2 signaling , 2020, Cell Death & Disease.

[13]  Y. Xiong,et al.  Targeting ferroptosis alleviates methionine‐choline deficient (MCD)‐diet induced NASH by suppressing liver lipotoxicity , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[14]  F. Gonzalez,et al.  SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis , 2020, Nature Communications.

[15]  Guangji Wang,et al.  Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[16]  Jiandie D. Lin,et al.  Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis. , 2019, Molecular cell.

[17]  J. Wan,et al.  n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review , 2019, Critical reviews in food science and nutrition.

[18]  M. Orozco,et al.  Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease , 2019, Cell.

[19]  T. Luedde,et al.  Apoptosis and necroptosis in the liver: a matter of life and death , 2018, Nature Reviews Gastroenterology & Hepatology.

[20]  M. Yamazaki,et al.  Apoptosis and non-alcoholic fatty liver diseases , 2018, World journal of gastroenterology.

[21]  B. Neuschwander‐Tetri,et al.  Mechanisms of NAFLD development and therapeutic strategies , 2018, Nature Medicine.

[22]  J. Lykkesfeldt,et al.  Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease , 2018, Cellular and Molecular Life Sciences.

[23]  A. Feldstein,et al.  Triggering and resolution of inflammation in NASH , 2018, Nature Reviews Gastroenterology & Hepatology.

[24]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps: The Biology of Chromatin Externalization. , 2018, Developmental cell.

[25]  V. Papayannopoulos.  Neutrophil extracellular traps in immunity and disease , 2017, Nature Reviews Immunology.

[26]  B. Suratt,et al.  Isolation and Characterization of Mouse Neutrophils. , 2018, Methods in molecular biology.

[27]  A. Kronbichler,et al.  Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review. , 2017, Autoimmunity reviews.

[28]  C. Weber,et al.  Neutrophils as protagonists and targets in chronic inflammation , 2017, Nature Reviews Immunology.

[29]  P. Kubes,et al.  An emerging role for neutrophil extracellular traps in noninfectious disease , 2017, Nature Medicine.

[30]  C. Weber,et al.  Neutrophil Extracellular Traps in Atherosclerosis and Atherothrombosis , 2017, Circulation research.

[31]  Yohei Fujishima,et al.  Rapid isolation of murine primary hepatocytes for chromosomal analysis , 2017, In Vitro Cellular & Developmental Biology - Animal.

[32]  M. Dessing,et al.  Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps. , 2017, Kidney international.

[33]  A. Federico,et al.  Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years , 2017, Molecules.

[34]  Y. Koyama,et al.  Liver inflammation and fibrosis. , 2017, The Journal of clinical investigation.

[35]  F. Chilton,et al.  Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes. , 2016, European journal of pharmacology.

[36]  E. Bugianesi,et al.  Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults. , 2016, Clinics in liver disease.

[37]  A. McCullough,et al.  Natural History of Nonalcoholic Fatty Liver Disease , 2016, Digestive Diseases and Sciences.

[38]  A. Warnatsch,et al.  Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis , 2015, Science.

[39]  C. Kahn,et al.  Diabetes primes neutrophils to undergo NETosis, which impairs wound healing , 2015, Nature Medicine.

[40]  Mary E Rinella,et al.  Nonalcoholic fatty liver disease: a systematic review. , 2015, JAMA.

[41]  Wenjun Yang,et al.  Neutrophils Play a Crucial Role in the Early Stage of Nonalcoholic Steatohepatitis via Neutrophil Elastase in Mice , 2015, Cell Biochemistry and Biophysics.

[42]  C. Byrne,et al.  NAFLD: a multisystem disease. , 2015, Journal of hepatology.

[43]  L. Galluzzi,et al.  Decoding cell death signals in liver inflammation. , 2013, Journal of hepatology.

[44]  M. Pallardy,et al.  An Improved Strategy to Recover Large Fragments of Functional Human Neutrophil Extracellular Traps , 2013, Front. Immunol..

[45]  S. Maithel,et al.  Chemotherapy-Associated Liver Injury: Impact on Surgical Management of Colorectal Cancer Liver Metastases , 2010, Annals of Surgical Oncology.

[46]  S. Rensen,et al.  Gastrointestinal , Hepatobiliary and Pancreatic Pathology Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic Steatohepatitis , 2009 .

[47]  S. Caldwell,et al.  Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. , 2009, Journal of hepatology.

[48]  Xia Zhang,et al.  The Isolation and Characterization of Murine Macrophages , 2008, Current protocols in immunology.

[49]  M. Diez,et al.  Liver lipid metabolism. , 2008, Journal of animal physiology and animal nutrition.

[50]  Michelle M Wiest,et al.  A lipidomic analysis of nonalcoholic fatty liver disease , 2007, Hepatology.

[51]  P. Puvanachandra,et al.  Hepatology outpatient service provision in secondary care: a study of liver disease incidence and resource costs. , 2007, Clinical medicine.

[52]  Robert V Farese,et al.  Triglyceride accumulation protects against fatty acid-induced lipotoxicity , 2003, Proceedings of the National Academy of Sciences of the United States of America.